Clinical Trial Update: Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages [Phase 1]

View source ↗

Summary

A Phase 1 trial update comparing pharmacodynamic effects of different glucagon dosages in individuals with Type 1 diabetes mellitus; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Diabetes Mellitus Type 1 | Phase 1 | Status: COMPLETED